SWOG clinical trial number
              SWOG-9107
          A Phase II Pilot Study of High Dose 24-Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA for Patients with Colorectal Cancer
Closed
      
  Phase
              Accrual
  
                          
      70%
      
  
    Published
      
  Abbreviated Title
              A Phase II Pilot Study of High Dose 24-Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA for Patients with Colorectal Cancer
          Activated
              01/01/1993
          Closed
              08/01/1994
          Publication Information Expand/Collapse
2004
A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: A Southwest Oncology Group study
